Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR

Journal of Virology

Volumn 76, Issue 12, 2002, Pages 6213-6223

  Fakhari, Farnaz D ^a   Dittmer, Dirk P ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; MESSENGER RNA;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; HERPES VIRUS; HUMAN HERPESVIRUS 8; LYSIS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS GENOME; VIRUS REACTIVATION; VIRUS TRANSCRIPTION;

CELL LINE; DNA PRIMERS; GENOME, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS LATENCY;

EID: 0036100266     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.12.6213-6223.2002     Document Type: Article

References (77)

1. Kaposi's sarcoma
2. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
3. Human herpesvirus 8 in Brazilian Amerindians: A hyperendemic population with a new subtype
4. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
5. Predicting DNA duplex stability from the base sequence
6. HHV-8 peripheral-blood viral load and the titer of antibodies against HHV-8
7. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
8. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
9. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene
10. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome
11. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells
12. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells
13. Exploring the metabolic and genetic control of gene expression on a genomic scale
14. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
15. Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice
16. Cluster analysis and display of genome-wide expression patterns
17. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
18. p53 inhibition by the LANA protein of KSHV protects against cell death
19. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
20. KSHV antibodies among Americans. Italians, and Ugandans with or without Kaposi's sarcoma
21. Ordering of human bone marrow B lymphocyte precursors by single cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci
22. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus
23. KSHV strains: The origins and global spread of the virus
24. Real-time quantitative PCR
25. The transcriptional program in the response of human fibroblasts to serum
26. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays
27. Differential Regulation of the overlapping Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) vGCR (orf74) and LANA (orf73) promoter
28. Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene
29. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus
30. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
31. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome
32. Quantitative analysis of human herpesvirus 8 viral load using a realtime PCR assay
33. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: Coordinate regulation with c-fos or c-myc
34. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein
35. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors
36. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients
37. Bone marrow failure associated with human herpesvirus 8 infection after transplantation
38. Sexual transmission and the natural history of human herpesvirus 8 infection
39. Amplification of cDNA ends based on template-switching effect and step-out PCR
40. Different strategies of differential display: Areas of application
41. Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation
42. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma
43. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene
44. Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas
45. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity?
46. Cellular localisation of HHV-8 in Castleman's disease: Is there a link with lymph node vascularity?
47. Mucosal shedding of human herpesvirus 8 in men
48. Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus)
49. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end
50. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1
51. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene hras transforms primary rat cells
52. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen
53. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells
54. Lyric growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
55. Epstein-Barr virus
56. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53
57. Herpesviridae
58. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
59. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus
60. Human herpesvirus 8 k1-associated nuclear factor-KB-dependent promoter activity: Role in Kaposi's sarcoma inflammation?
61. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)
62. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter
63. Regulation of average length of complex PCR product
64. Antibodies against human herpesvirus 8 in black South African patients with cancer
65. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
66. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
67. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression
68. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line
69. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma
70. Human herpesvirus type 8 and Kaposi's sarcoma
71. Detection of Kaposi sarcoma-associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma
72. Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
73. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma
74. Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: Characterization of antiherpesvirus agents
75. Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: Evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate